However, intact AnxA1 protein was found to be increased in the brain of both AD patients and animal models and induce the clearance and degradation of the amyloid-β peptide in vitro by acting on formyl peptide receptor-like 1 (FPRL1) [91]. Here, FPR2 is linked to Alzheimer disease.